Dual Regulatory Roles of Phosphatidylinositol 3-Kinase in IFN Signaling1
暂无分享,去创建一个
A. Verma | L. Platanias | E. Eklund | S. Brachmann | E. Fish | A. Sassano | S. Kaur | B. Majchrzak-Kita | A. Joseph
[1] L. Platanias,et al. Role of the Akt pathway in mRNA translation of interferon-stimulated genes , 2008, Proceedings of the National Academy of Sciences.
[2] N. Sonenberg,et al. Translational control of the innate immune response through IRF-7 , 2008, Nature.
[3] R. Coffman,et al. PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation , 2008, The Journal of experimental medicine.
[4] R. Kaur,et al. Activation of Nonreceptor Tyrosine Kinase Bmx/Etk Mediated by Phosphoinositide 3-Kinase, Epidermal Growth Factor Receptor, and ErbB3 in Prostate Cancer Cells* , 2007, Journal of Biological Chemistry.
[5] D. McKay,et al. Phosphatidylinositol 3′-Kinase Is a Critical Mediator of Interferon-γ-Induced Increases in Enteric Epithelial Permeability , 2007, Journal of Pharmacology and Experimental Therapeutics.
[6] K. Knobeloch,et al. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses , 2007, Proceedings of the National Academy of Sciences.
[7] N. Sonenberg,et al. Regulatory Effects of Mammalian Target of Rapamycin-activated Pathways in Type I and II Interferon Signaling* , 2007, Journal of Biological Chemistry.
[8] D. Grandér,et al. Phosphoinositide 3-kinase regulates a subset of interferon-alpha-stimulated genes. , 2007, Experimental cell research.
[9] G. Stark,et al. Complex modulation of cell type-specific signaling in response to type I interferons. , 2006, Immunity.
[10] A. Reder,et al. Therapeutic role of beta-interferons in multiple sclerosis. , 2006, Pharmacology & therapeutics.
[11] L. Platanias. Introduction: interferon signals: what is classical and what is nonclassical? , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[12] L. Platanias,et al. The PI3' kinase pathway in interferon signaling. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[13] A. Verma,et al. Role of the p38 mitogen-activated protein kinase pathway in cytokine-mediated hematopoietic suppression in myelodysplastic syndromes. , 2005, Cancer research.
[14] N. Hay,et al. The Akt-mTOR tango and its relevance to cancer. , 2005, Cancer cell.
[15] B. McManus,et al. Gamma Interferon-Inducible Protein 10 Induces HeLa Cell Apoptosis through a p53-Dependent Pathway Initiated by Suppression of Human Papillomavirus Type 18 E6 and E7 Expression , 2005, Molecular and Cellular Biology.
[16] L. Platanias. Mechanisms of type-I- and type-II-interferon-mediated signalling , 2005, Nature Reviews Immunology.
[17] S. Parmar,et al. Role of protein kinase C-δ (PKC-δ) in the generation of the effects of IFN-α in chronic myelogenous leukemia cells , 2005 .
[18] Hideo Negishi,et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses , 2005, Nature.
[19] Sheila M. Thomas,et al. Role of Phosphoinositide 3-Kinase Regulatory Isoforms in Development and Actin Rearrangement , 2005, Molecular and Cellular Biology.
[20] Michael G. Kharas,et al. ABL oncogenes and phosphoinositide 3-kinase: mechanism of activation and downstream effectors. , 2005, Cancer research.
[21] Ming Yan,et al. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection , 2004, Nature Medicine.
[22] L. Platanias,et al. Interferon-gamma engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein. , 2004, Experimental cell research.
[23] G. G. Choudhury. A Linear Signal Transduction Pathway Involving Phosphatidylinositol 3-Kinase, Protein Kinase Cϵ, and MAPK in Mesangial Cells Regulates Interferon-γ-induced STAT1α Transcriptional Activation* , 2004, Journal of Biological Chemistry.
[24] D. Levy,et al. Role of p38α Map Kinase in Type I Interferon Signaling* , 2004, Journal of Biological Chemistry.
[25] J. Dennis,et al. Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. , 2003, JAMA.
[26] N. Sonenberg,et al. Activation of the p70 S6 Kinase and Phosphorylation of the 4E-BP1 Repressor of mRNA Translation by Type I Interferons* , 2003, Journal of Biological Chemistry.
[27] J. Lord,et al. Inhibition of Neutrophil Apoptosis by Type 1 IFN Depends on Cross-Talk Between Phosphoinositol 3-Kinase, Protein Kinase C-δ, and NF-κB Signaling Pathways1 , 2003, The Journal of Immunology.
[28] A. Verma,et al. Activation of Protein Kinase Cδ by IFN-γ1 , 2003, The Journal of Immunology.
[29] J. Prieto,et al. Interferon beta promotes survival in primary astrocytes through phosphatidylinositol 3-kinase , 2003, Journal of Neuroimmunology.
[30] Guo-Ping Zhou,et al. Triggering the Interferon Antiviral Response Through an IKK-Related Pathway , 2003, Science.
[31] G. Feldman,et al. A PI‐3 kinase‐dependent, Stat1‐independent signaling pathway regulates interferon‐stimulated monocyte adhesion , 2003, Journal of leukocyte biology.
[32] A. Verma,et al. Cutting Edge: Activation of the p38 Mitogen-Activated Protein Kinase Signaling Pathway Mediates Cytokine-Induced Hemopoietic Suppression in Aplastic Anemia1 , 2002, The Journal of Immunology.
[33] Lewis C Cantley,et al. The phosphoinositide 3-kinase pathway. , 2002, Science.
[34] D. Aaronson,et al. A Road Map for Those Who Don't Know JAK-STAT , 2002, Science.
[35] A. Verma,et al. Protein Kinase C-δ (PKC-δ) Is Activated by Type I Interferons and Mediates Phosphorylation of Stat1 on Serine 727* , 2002, The Journal of Biological Chemistry.
[36] G. Stark,et al. Roles of Phosphatidylinositol 3-Kinase in Interferon-γ-dependent Phosphorylation of STAT1 on Serine 727 and Activation of Gene Expression* , 2001, The Journal of Biological Chemistry.
[37] Amit Verma,et al. The p38 MAPK Pathway Mediates the Growth Inhibitory Effects of Interferon-α in BCR-ABL-expressing Cells* , 2001, The Journal of Biological Chemistry.
[38] B. Hallberg,et al. Interferon-α Promotes Survival of Human Primary B-Lymphocytes via Phosphatidylinositol 3-Kinase , 2001 .
[39] L. Pfeffer,et al. Interferon α/β Promotes Cell Survival by Activating Nuclear Factor κB through Phosphatidylinositol 3-Kinase and Akt* , 2001, The Journal of Biological Chemistry.
[40] L. Platanias,et al. Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway. , 2000, Biochemical and biophysical research communications.
[41] L. Platanias,et al. Signaling pathways activated by interferons. , 1999, Experimental hematology.
[42] G. Stark,et al. How cells respond to interferons. , 1998, Annual review of biochemistry.
[43] K. Alitalo,et al. The Bmx tyrosine kinase induces activation of the Stat signaling pathway, which is specifically inhibited by protein kinase Cdelta. , 1997, Blood.
[44] M. White,et al. The IRS-pathway operates distinctively from the Stat-pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or interferon-alpha receptors. , 1997, Blood.
[45] I. Kerr,et al. Janus Kinase-dependent Activation of Insulin Receptor Substrate 1 in Response to Interleukin-4, Oncostatin M, and the Interferons* , 1997, The Journal of Biological Chemistry.
[46] J. Darnell. STATs and gene regulation. , 1997, Science.
[47] M. White,et al. Activation of the phosphatidylinositol 3-kinase serine kinase by IFN-alpha. , 1997, Journal of immunology.
[48] C. Glass,et al. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[49] M. White,et al. The Type I Interferon Receptor Mediates Tyrosine Phosphorylation of Insulin Receptor Substrate 2 (*) , 1996, The Journal of Biological Chemistry.
[50] M. White,et al. Interferon-α Engages the Insulin Receptor Substrate-1 to Associate with the Phosphatidylinositol 3′-Kinase (*) , 1995, The Journal of Biological Chemistry.
[51] J. Darnell,et al. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.
[52] S. Baron,et al. The interferons. Mechanisms of action and clinical applications. , 1991, JAMA.
[53] M. White,et al. Activation of the Phosphatidylinositol 3-Kinase Serine Kinase by 1 FNa ’ , 2001 .
[54] L. Platanias,et al. Activation of the p 38 Mitogen-activated Protein Kinase by Type I Interferons , 1999 .
[55] K C Zoon,et al. Interferons and their actions. , 1987, Annual review of biochemistry.
[57] G. Tellides,et al. Interferon- (cid:1) Induces Fas Trafficking and Sensitization to Apoptosis in Vascular Smooth Muscle Cells via a PI3K- and Akt-Dependent Mechanism , 2022 .